Author

Sudipta Sonar

Translational Health Science and Technology InstituteORCID 0000-0002-6452-6015Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Bioinformatics· 1 Immunology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Research Focus:host-pathogen & immune response· 1 Organism:human· 1 Assay:proteomics· 1 Approach:statistical model· 1 Organism:virus· 1

Frequent Co-Authors

A. Surendranath· 1 shared Abhisek DwivedyiD· 1 shared Anant MohaniD· 1 shared Balwant SinghiD· 1 shared Bichitra Kumar BiswaliD· 1 shared Chaman Prasad· 1 shared Deepsikha KariD· 1 shared Diwakar Rathour· 1 shared

Activity by Year

2021-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 24 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperImmunology

A. Surendranath

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

ImmunologybioRxivPreprintJul 20, 2026

A human monoclonal antibody from hybrid immunity exhibits exceptional neutralization breadth against antigenically divergent contemporary Omicron JN.1 lineage variants

Diwakar Rathour, Shweta Shrivas, Naresh Kumar…·Jayanta Bhattacharya

This paper identifies a monoclonal antibody from hybrid immunity that broadly neutralizes multiple Omicron variants by targeting conserved epitopes on the spike protein.

DOI 10.64898/2026.07.20.739483

humanproteomics

𝕏 PostBluesky

BioinformaticsPLoS Computational BiologyPeer-reviewedSep 13, 2021

Characterization of the NiRAN domain from RNA-dependent RNA polymerase provides insights into a potential therapeutic target against SARS-CoV-2

Abhisek Dwivedy, Richard Mariadasse, Mohammed Ahmad…·Bichitra Kumar Biswal

This study characterizes the NiRAN domain of SARS-CoV-2 RdRp, identifies its kinase-like activity, and predicts potential inhibitors for drug repurposing.

29 citations

virusstatistical model

𝕏 PostBluesky